GMED
Globus Medical, Inc.NYSEHealthcare$87.92+0.21%ClosedMarket Cap: $11.89B
As of 2026-04-06
Valuation
P/E (TTM)
22.11
PEG
0.05
P/B
2.60
P/S
4.05
EV/EBITDA
14.05
DCF Value
$38.42
FCF Yield
4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.4%
Operating Margin
16.3%
Net Margin
18.3%
ROE
12.4%
ROA
17.2%
ROIC
8.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $826.4M | 72.0% | $171.7M | $140.6M | $1.01 | — |
| FY 2025 | $2.94B | 67.4% | $479.8M | $537.9M | $3.92 | — |
| Q3 2025 | $769.0M | 63.3% | $135.0M | $119.0M | $0.88 | — |
| Q2 2025 | $745.3M | 66.6% | $76.1M | $202.8M | $1.49 | — |
| Q1 2025 | $598.1M | 67.3% | $97.0M | $75.5M | $0.54 | — |
| Q4 2024 | $657.3M | 59.9% | $60.3M | $26.5M | $0.19 | — |
| FY 2024 | $2.52B | 58.9% | $166.0M | $103.0M | $0.75 | — |
| Q3 2024 | $625.7M | 56.8% | $48.1M | $51.8M | $0.38 | — |
| Q2 2024 | $629.7M | 58.7% | $49.6M | $31.8M | $0.23 | — |
| Q1 2024 | $606.7M | 60.2% | $8.0M | $-7.1M | $-0.05 | — |
| Q4 2023 | $616.5M | 56.9% | $10.1M | $15.0M | $0.11 | — |
| FY 2023 | $1.57B | 65.1% | $133.1M | $122.9M | $1.07 | — |